https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-positive-preclinical-results-for-ht-kit-in-aggressive-cancer-gastrointestinal-stromal-tumors-gist-ht-kit-triggered-significant-tumor-cell-death-as-early-as-24-hours-post-treatment-302403945.html
